The case for intravenous arginine stimulation in lieu of mixed-meal tolerance tests as outcome measure for intervention studies in recent-onset type 1 diabetes.
about
CXCR1/2 inhibition enhances pancreatic islet survival after transplantation.Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes.Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetesImmunologic and metabolic biomarkers of β-cell destruction in the diagnosis of type 1 diabetes.A SNP in G6PC2 predicts insulin secretion in type 1 diabetes.
P2860
The case for intravenous arginine stimulation in lieu of mixed-meal tolerance tests as outcome measure for intervention studies in recent-onset type 1 diabetes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
The case for intravenous argin ...... recent-onset type 1 diabetes.
@en
The case for intravenous argin ...... recent-onset type 1 diabetes.
@nl
type
label
The case for intravenous argin ...... recent-onset type 1 diabetes.
@en
The case for intravenous argin ...... recent-onset type 1 diabetes.
@nl
prefLabel
The case for intravenous argin ...... recent-onset type 1 diabetes.
@en
The case for intravenous argin ...... recent-onset type 1 diabetes.
@nl
P2093
P1433
P1476
The case for intravenous argin ...... recent-onset type 1 diabetes.
@en
P2093
Carla Greenbaum
Catherine Pihoker
Kristy Seidel
P304
P356
10.2337/DIACARE.27.5.1202
P407
P577
2004-05-01T00:00:00Z